EUROPEAN RENAL ASSOCIATION - EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION
Services
How to use the platform
Build a poster
MANAGE ORDERS
FAQs
Contact
HOMEPAGE
Virtual Poster Gallery
PrintingOnline for Collection on-site
Accredited Training
DOI - Digital Object Identifier
What is PosterSessionOnline?
How to send your poster
How to visit the Virtual Poster Gallery
How to build a poster
How to reduce a poster to less than 2 Mb
PosterSessionOnline Image Editor
How to build a poster with our templates
How to work with a template
Templates and instructions
Discussion forum -
49th ERA-EDTA Congress
Topic -
Cell signalling / Pathophysiology
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
Poster:
18
Visits:
791
Title:
Arachidonic acid stimulates Ca2 entry into mouse TAL cells through an apical TRPM7-like Ca2-permeable non-selective cation channel
Authors:
Marc Paulais ,
Centre:
UMRS872 - ERL7226
You must be registered to reply or comment.
ARACHIDONIC ACID STIMULATES CA2 ENTRY INTO MOUSE TAL CELLS THROUGH AN APICAL TRPM7-LIKE CA2-PERMEABLE NON-IVE CATION CHANNEL
Marc Paulais
Thread initiator
Subspeciality
Reg:
5/2/2012 4:14:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.
Comment added on 5/2/2012 4:14:00 PM
You must be registered to reply or comment.
Most viewed poster for this congress
Poster:
424
Visits:
2891
Title:
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Glomerulonephritides: an Immunohystochemical expression analysis
Authors:
Giuseppe Coppolino ,
Centre:
Chair of Nephrology, University Magna Graecia of Catanzaro, Catanzaro, Italy
Poster most viewed in this topic
Poster:
35
Visits:
1205
Title:
Dimerization of the calcium-sensing receptor and response to cinacalcet HCl
Authors:
Hansjrg Rothe , Warren B ShapiroMarkus Ketteler
Centre:
Klinikum Coburg
View Poster Gallery
Back to congress home
Other Congresses
About us
|
Terms and Conditions
|
Special Access